MAPT and Alzheimer disease: New studies suggest that gut microbiota dysbiosis contributes to AD pathogenesis by increasing systemic inflammation, impairing intestinal barrier function, and enhancing amyloid and tau pathology [13]—ongoing debates center on whether microbiota alterations causally drive or merely reflect neurodegeneration [14].